Table 1.
Demographics, Comorbidities, CRS Characteristics and Olfactory Metrics (n=221 patients)
| Variable | Mean (SD) | Count (%) | |
|---|---|---|---|
| Demographics | |||
| Age (years) | 49.3 (15.9) | ||
| Sex | Female | 120 (54.3%) | |
| Male | 101 (45.7%) | ||
| Race | African American | 15 (6.8%) | |
| Asian | 9 (4.1%) | ||
| Other | 5 (2.3%) | ||
| White | 192 (86.9%) | ||
| Ethnicity | Hispanic/Latino | 11 (5.0%) | |
| Non-Hispanic/Latino | 210 (95.0%) | ||
| Education (years) | 14.8 (2.4) | ||
| Comorbidities | |||
| Asthma | 97 (43.9%) | ||
| AERD | 14 (6.3%) | ||
| Allergy by Testing | 140 (63.4%) | ||
| COPD | 12 (5.4%) | ||
| Depression | 23 (10.4%) | ||
| Fibromyalgia | 7 (3.2%) | ||
| Immunodeficiency | 9 (4.1%) | ||
| Ciliary dysfunction | 2 (0.9%) | ||
| Cystic fibrosis | 7 (3.2%) | ||
| Autoimmune disease | 9 (4.1%) | ||
| Diabetes (type 2) | 20 (9.1%) | ||
| CRS characteristics | |||
| Previous Sinus Surgery | 130 (58.8%) | ||
| CRSwNP | 138 (62.4%) | ||
| Endoscopy Score | 5.6 (3.8) | ||
| CT Score | 11.7 (6.3) | ||
| SNOT22 | 53.3 (21.6) | ||
| Olfactory metrics | |||
| SIT Score Overall (n=104 patients) | 28.0 (9.2) | ||
| Anosmic | 11.2 (3.1) | 20 (19.2%) | |
| Hyposmic | 29.8 (3.7) | 54 (51.9%) | |
| Normosmic | 35.9 (1.3) | 30 (28.8%) | |
| QOD-NS Overall (n=104 patients) | 37.1 (12.9) | ||
| Anosmic (by SIT) | 29.2 (12.2) | 20 (19.2%) | |
| Hyposmic (by SIT) | 38.3 (12.7) | 54 (51.9%) | |
| Normosmic (by SIT) | 39.8 (11.2) | 30 (28.8%) | |
SD: Standard deviation; AERD: Aspirin exacerbated respiratory disease; COPD: Chronic obstructive pulmonary disease; CRS: Chronic rhinosinusitis; NP: Nasal polyps; CT: Computed tomography; SNOT: Sinonasal Outcome Test; SIT: Smell Identification Test; QOD-NS: Questionnaire of Olfactory Disorders